Teprotumumab for Thyroid-Associated Ophthalmopathy

BACKGROUND: Thyroid-associated ophthalmopathy, a condition commonly associated with Graves’ disease, remains inadequately treated. Current medical therapies, which primarily consist of glucocorticoids, have limited efficacy and present safety concerns. Inhibition of the insulin-like growth factor I...

詳細記述

保存先:
書誌詳細
出版年:N Engl J Med
主要な著者: Smith, Terry J., Kahaly, George J., Ezra, Daniel G., Fleming, James C., Dailey, Roger A., Tang, Rosa A., Harris, Gerald J., Antonelli, Alessandro, Salvi, Mario, Goldberg, Robert A., Gigantelli, James W., Couch, Steven M., Shriver, Erin M., Hayek, Brent R., Hink, Eric M., Woodward, Richard M., Gabriel, Kathleen, Magni, Guido, Douglas, Raymond S.
フォーマット: Artigo
言語:Inglês
出版事項: 2017
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5718164/
https://ncbi.nlm.nih.gov/pubmed/28467880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1614949
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料